Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
Stefoni
Vittorio
V
Alinari
Lapo
L
Musuraca
Gerardo
G
Tani
Monica
M
Marchi
Enrica
E
Gabriele
Annalisa
A
Fina
Mariapaola
M
Pileri
Stefano
S
Baccarani
Michele
M
Zinzani
Pier Luigi
PL
D000284:Administration, Oral; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D013997:Time Factors; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine